MyFinsight
Home
About
Contact
sndx: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, SNDX has $551,792K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
551,792
596,149
Total stockholders equity
115,430
157,424
Total liabilities and stockholders equity
551,792
596,149
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$9,517K
Collaboration receivable, net
$15,736K
Short-term deposits
$18,195K
Inventory
$25,000K
Accounts receivable, net
$25,403K
Short-term investments
$319,171K
Cash and cash
equivalents
$116,808K
Restricted cash
$217K
Right-of-use asset, net
$1,471K
Property and equipment,
net
$128K
Long-term investments
$20,146K
Total current assets
$529,830K
Total assets
$551,792K
Total liabilities and
stockholders equity
$551,792K
Total stockholders
equity
$115,430K
Total liabilities
$436,362K
Accumulated deficit
-$1,438,566K
Accumulated other
comprehensive gain
$525K
Additional paid-in capital
$1,553,462K
Total long-term
liabilities
$322,175K
Total current
liabilities
$114,187K
Common stock, 0.0001
par value,...
$9K
Right-of-use liability, less
current portion
$1,190K
Royalty interest
financing liability, less...
$320,985K
Current portion of
capital lease
$2K
Current portion of
right-of-use liability
$329K
Current portion of
royalty interest...
$22,925K
Accrued expenses and
other current...
$77,105K
Accounts payable
$13,826K
Subscribe for Financial Insights
Syndax Pharmaceuticals Inc (SNDX)
Syndax Pharmaceuticals Inc (SNDX)